Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
Clinical trial NCT04163419 · UNKNOWN
Trial details
- NCT number
- NCT04163419
- Sponsor
- Massachusetts General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2022-09-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.